Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Pharmacies are turning away immunocompromised patients seeking 4th covid shot

by Medical Finance
in Coronavirus
Omicron variant found to be much less sensitive to neutralizing antibodies than Delta
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Patients with weakened immune systems — who are at high risk from covid-19 — say pharmacies are turning them away when they seek additional vaccine doses recommended by federal health officials.

Alyson Smith became eligible this month for a fourth vaccine dose because her medications leave her immunocompromised.

Although the Centers for Disease Control and Prevention encourages most adults to receive a total of three mRNA vaccines — two “primary” vaccinations and a booster — the agency now advises people with weak immune systems to receive three primary shots plus a booster, for a total of four doses.

Many people are confused about the difference between a primary vaccine series and a booster. A primary vaccine series helps people build antibodies to a new pathogen, while a booster combats waning immunity.

As Smith learned, many pharmacists are unaware that the CDC’s vaccine guidance has changed.

Smith booked her vaccine appointment online. But when she showed up at a Chicago-area Walgreens for the appointment Jan. 19, an employee told her the pharmacy chain wasn’t administering fourth doses to anyone.

Smith said she’s frustrated that vulnerable people are being forced to make multiple visits to crowded pharmacies and supermarkets, where many customers are unmasked.

“I feel for the pharmacists, because they’re overwhelmed like everyone else,” said Smith, 52. “But two years into the pandemic, there is a corporate responsibility to take action when the guidance comes down.”

In a written statement, Walgreens said it has administered thousands of fourth doses to immunocompromised people. “As vaccination guidelines continue to evolve, we make every effort to continuously update our pharmacy teams.”

The confusion stems from recent updates in vaccine advice for immunocompromised people, as well as a change in the interval between the end of a primary vaccine series and a booster.

  • In August, the CDC began allowing immunocompromised people to receive a third dose of mRNA vaccine as part of their primary vaccination.
  • In October, the CDC quietly updated its website to allow people with suppressed immune systems to receive a fourth shot as a booster.
  • In January, the agency shortened the time that anyone must wait for a booster from six months to five.

People who received the one-dose Johnson & Johnson vaccine are eligible for a single booster, for a total of two shots, according to the CDC.

Given how often vaccine guidelines have been revised in recent months, some pharmacists have had a hard time keeping pace, said Mitchel Rothholz, chief of governance and state affiliates at the American Pharmacists Association. Pharmacy employees have coped with an ever-expanding workload but a deepening shortage of employees during the pandemic, he said.

“I don’t know any provider who wants to turn away a patient,” Rothholz said. “The CDC continues to make updates, and it’s becoming very difficult for providers at the grassroots level to keep up. I can understand why a pharmacist would say, ‘Corporate hasn’t given us the green light.'”

Confusion about who is eligible for a fourth shot “was inevitable, although I’m not saying it’s right or wrong,” he said.

Yet many patients and their doctors are frustrated.

If patients keep up with the latest guidelines, they ask, why can’t their pharmacy?

“It’s ridiculous,” said Dr. Dorry Segev, a transplant surgeon and researcher at Johns Hopkins University. “CDC makes it very clear that it’s allowed, and even people who print out the CDC guidance and take it to their pharmacies are being turned away.”

Charis Hill, 34, joined a chorus of immune-suppressed people venting their concerns on social media in recent days. When Hill tweeted Jan. 21 that Rite Aid should better educate its staff, the retailer tweeted back that day, saying, “We’re very sorry you didn’t have a great experience, Charis. Please check back with us early next month for more information regarding the fourth dose.”

In a written statement, Rite Aid said it continually educates its staff as CDC advice changes, and “is looking into the response that was provided to the customer on social media.”

Dr. Shikha Jain, an assistant professor of medicine at the University of Illinois Cancer Center in Chicago, said patients in rural areas often drive long distances to look for vaccines. One of her patients was “almost in tears” after being turned away. Jain tried to help by calling the pharmacy but was on hold so long that she had to hang up to see patients.

Jain said the CDC needs to do a better job educating doctors, pharmacists, and patients.

The CDC did not respond to a request for comment before publication.

Teresa Strahlman, 61, said she’s immune-compromised due to medications she takes for lupus, an autoimmune disease. But the Maryland woman said she didn’t realize she was eligible for a fourth dose until reading a KHN post on Facebook. “I had no idea, and I have a million doctors,” Strahlman said. “No one has said anything to me.”

The CDC estimates that 2.7% of adults — or 7 million people — are immunocompromised, a group that includes people with medical conditions that dampen their immune response, as well as those taking immune-suppressing drugs because of organ transplants, cancer, or autoimmune diseases.

Some immunocompromised people say that being turned away from a pharmacy is especially frustrating, given all that they have sacrificed during the pandemic.

Linda Rushing, 74, has given up attending church services in person, although she’s deeply religious, because of a weakened immune system that leaves her prone to a variety of infections.

Rushing made three visits to local pharmacies before finding someone to administer her fourth shot.

“It’s a tragedy to need help and not be able to get it,” said Rushing, of Rowlett, Texas, whose daughter and granddaughter are also immunocompromised. “I don’t want covid. I don’t want to give it to anybody, and I’m trying to do everything I can not to die from it.”




Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose. Image Credit: peterschreiber.media / Shutterstock.com

Third dose of mRNA COVID vaccine induces strong immunity in older adults

by Medical Finance
May 20, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen has been circulating since the end of 2019, causing the ongoing...

(A) Schematic of the physical changes that take place when an airborne aqueous droplet equilibrates to the surrounding relative humidity. On the left (blue box) the particle is an aqueous homogenous sphere. As the particle equilibrates to a sub-saturated RH, low-solubility solutes can precipitate inclusions within the droplet (yellow box). At a sufficiently low RH, the dominant solute (NaCl) can crystallize causing the particle to effloresce (black box). (B) Schematic of the CELEBS technique. Virus-containing particles are levitated under controlled conditions and then deposited into media which is then plated onto a cell culture. By enumerating the cytopathic effect from that deposition, the amount of virus present can be quantified. (C) Schematic of the CK-EDB technique. Particles generated by the same droplet dispensers used in CELEBS are levitated under controlled conditions in the path of a laser. The physical changes that take place in that particle are studied through analysis of the light scattered by that particle.

Airborne decay of SARS-CoV-2 occurs within minutes

by Medical Finance
May 20, 2022
0

Understanding the factors that influence the airborne survival of viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...

Study: COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Image Credit: alinabuphoto/Shutterstock

The effect of COVID-19 on routine immunizations for vaccine-preventable diseases

by Medical Finance
May 20, 2022
0

The ongoing coronavirus disease-19 (COVID-19) pandemic, caused by a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has...

Study: Persistence of endogenous SARS-CoV-2 and pepper mild mottle virus RNA in wastewater settled solids. Image Credit: NIAID

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

by Medical Finance
May 20, 2022
0

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient...

Study: Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants. Image Credit: Studio Romantic/Shutterstock

Evaluating effectiveness of the COVID-19 mRNA-1273 vaccine against Omicron and Delta variants

by Medical Finance
May 20, 2022
0

In a study recently published on the medRxiv* pre-print server, a team of researchers investigated the effectiveness of one to...

Study: Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Image Credit: Pormezz / Shutterstock

A common cold may boost the immune system against COVID-19

by Medical Finance
May 20, 2022
0

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at...

Next Post
Study: A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interface. Image Credit: MIA Studio/Shutterstock

Researchers investigate SARS-CoV-2 specific inflammatory response

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity. Image Credit: Anatomy Image
    Study looks at potential impact of BBIBPCorV and CoronaVac SARS-CoV-2 vaccines on thyroid
  • demand for us travel nurses plunges
    Travel nurses see swift change of fortunes as covid money runs dry
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply